By Malik Y. Kahook, MD
    Annual Meeting 2013

    In this companion to "Point: The Case for Generic Drugs," Dr. Malik Kahook discusses the advantages of branded glaucoma medications. He cites the manufacturing, stability, contaminant, and packaging issues with generics, asserting that the superior manufacturing criteria of their branded counterparts lead to greater safety and efficacy. Also discussed are the recent labeling issues in the news and the FDA's intentions in the matter.